title: [Drug therapy of depression in general practice].
abstract: The authors advocate use of the Montgomery-Asberg Depression Rating Scale in general practice as a screening instrument for depression. A score of 20 and above for more than two weeks indicates a need for treatment with antidepressant drugs. The treatment should continue with full dosage for at least two months after the patient has been cured. In order to maintain the patient's quality of life, reduce risk of drug-related toxicity and improve compliance, we recommend alfa-2-receptor blocker, a selective 5HT-re-uptake inhibitor or a selective monoamino-oxidase A inhibitor as the first drug choice for treatment of depression by general practitioners. Monitoring serum levels of the drug may be helpful, especially in persons who do not respond to treatment.
authors: Psykosomatisk avdeling, Rikshospitalet, Oslo.
authors: U F
authors: UF
authors: Malt
authors: S
authors: S
authors: Beckman
authors: O
authors: O
authors: Ekeberg
authors: B
authors: B
authors: Gunby
authors: J
authors: J
authors: Jørgensen
authors: O
authors: O
authors: Lingjaerde
authors: T
authors: T
authors: Skomedal
mesh_terms: D000928:Antidepressive Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy* / Q000191:economics; D005194:Family Practice; D006801:Humans
chemical_list: D000928:Antidepressive Agents
vernacular_title: Medikamentell behandling av depresjoner i allmennpraksis.